News &amp; Updates

Does MetS induce fibrosis progression/regression?

Metabolic syndrome (MetS) appears to contribute to greater histological severity in patients with nonalcoholic fatty liver disease (NAFLD) but does not seem to influence disease progression or regression, according to a study.

Does MetS induce fibrosis progression/regression?

In an updated analysis of the NATALEE* trial, the efficacy benefit of adjuvant ribociclib remains consistent even after the planned 3-year treatment duration for patients with HR+, ERBB2– early breast cancer (EBC).

NATALEE updates: Ribociclib benefit in HR+, ERBB– EBC sustained at 4 years

03 Feb 2026 by

NATALEE updates: Ribociclib benefit in HR+, ERBB– EBC sustained at 4 years

03 Feb 2026

Finerenone a viable option in primary aldosteronism treatment

The novel nonsteroidal mineralocorticoid receptor antagonist finerenone appears safe and efficacious in the treatment of primary aldosteronism, as shown in a study.

Finerenone a viable option in primary aldosteronism treatment

10-year data support antibiotics treatment of uncomplicated acute appendicitis

Among adults who received antibiotic treatment for uncomplicated acute appendicitis in the APPAC* trial, the number of recurrences and subsequent appendectomies at 10 years demonstrates the viability of this nonsurgical treatment approach, as reported by the investigators.

10-year data support antibiotics treatment of uncomplicated acute appendicitis

Semaglutide superior to dulaglutide, liraglutide for glycaemic control, weight loss in T2D

Treatment with semaglutide appears more effective than both dulaglutide and liraglutide for glycaemic control and weight loss in patients with type 2 diabetes (T2D), reports a China study. On the other hand, dulaglutide and liraglutide show similar clinical efficacy.

Semaglutide superior to dulaglutide, liraglutide for glycaemic control, weight loss in T2D

Serum albumin levels negatively linked to hypertension onset

Serum albumin may indirectly reduce the risk of hypertension by regulating obesity, inflammatory status, and fluid balance, suggests a study.

Serum albumin levels negatively linked to hypertension onset

02 Feb 2026

Obesity may raise risk of autoimmune diseases

Individuals with obesity appears to be at greater risk of developing autoimmune diseases, according to a systematic review and meta-analysis.

Obesity may raise risk of autoimmune diseases

02 Feb 2026

Proton therapy tied to increased risk of osteoradionecrosis

A study on patients with oropharyngeal squamous cell carcinoma (OPSCC) shows an association between proton therapy (PT) and a higher rate of osteoradionecrosis (ORN).

Proton therapy tied to increased risk of osteoradionecrosis

No increased cardiovascular risk for women discontinuing statins at pregnancy

Discontinuation of statins at pregnancy does not appear to contribute to increased cardiovascular (CV) risk for expectant mothers, including those at high CV risk, according to a study.

No increased cardiovascular risk for women discontinuing statins at pregnancy